AI assistant
Sending…
SRx Health Solutions, Inc. — Director's Dealing 2021
Sep 1, 2021
35114_dirs_2021-09-01_790193ae-e9ba-43fb-8394-673443b40787.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Better Choice Co Inc. (BTTR)
CIK: 0001471727
Period of Report: 2021-08-17
Reporting Person: Word John M III (Director, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-08-17 | Common Stock | P | 25000 | $3.36 | Acquired | 3207614 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 14335 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Purchase Warrants - Right to Buy | $7.5 | 2030-06-30 | Common Stock (83334.0) | 83334 | Direct |
| Purchase Warrants - Right to Buy | $7.5 | 2027-01-22 | Common Stock (4167.0) | 4167 | Indirect |
| Purchase Warrants - Right to Buy | $7.5 | 2027-01-22 | Common Stock (83334.0) | 83334 | Direct |
| Purchase Warrants - Right to Buy | $6.3 | 2030-06-30 | Common Stock (50000.0) | 50000 | Direct |
| Purchase Warrants - Right to Buy | $4.5 | 2026-10-01 | Common Stock (1666667.0) | 1666667 | Direct |
| Stock Options - Right to Buy | $7.74 | 2031-01-08 | Common Stock (16667.0) | 16667 | Direct |
| Purchase Warrants - Right to Buy | $10.92 | 2030-06-30 | Common Stock (812500.0) | 812500 | Direct |
| Stock Options - Right to Buy | $5.0 | 2031-07-08 | Common Stock (20000.0) | 20000 | Direct |
| Purchase Warrants - Right to Buy | $4.5 | 2026-10-01 | Common Stock (4334.0) | 4334 | Indirect |
| Purchase Warrants - Right to Buy | $25.5 | 2030-06-30 | Common Stock (917.0) | 917 | Direct |
Footnotes
F1: Options exercisable according to the vesting terms in the related option agreement.
More from SRx Health Solutions, Inc.
Regulatory Filings
2026
Apr 22
Regulatory Filings
2026
Apr 17
Merger & Acquisition
2026
Apr 14
Capital/Financing Update
2026
Mar 18
Capital/Financing Update
2026
Mar 3
Delisting Announcement
2026
Feb 20
Capital/Financing Update
2026
Feb 13
Capital/Financing Update
2026
Feb 13
Interim / Quarterly Report
2026
Feb 13
Major Shareholding Notification
2026
Feb 12